Brain-associated inhibitor of tissue-type plasminogen activator
View Patent ↗The present invention relates to a novel BAIT protein which is a member of serpin superfamily which is expressed primarily in brain tissue. In particular, isolated nucleic acid molecules are provided encoding the human and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of BAIT activity. Also provided are diagnostic methods for detecting nervous system-related disorders and therapeutic methods for treating nervous system-related disorders. Additionally, the present invention is related to methods of treating patients with BAIT polynucleotides or polypeptides, wherein said patients have had seizures or epilepsy.
1. A method for inhibiting seizure generalization comprising administering to a patient in need thereof an effective amount of an isolated polypeptide comprising an amino acid sequence at least 97% identical to a sequence selected from the group consisting of:
(a) the amino acid sequence of the BAIT polypeptide having the complete amino acid sequence in SEQ ID NO:2;
(b) the amino acid sequence of the mature BAIT polypeptide having the amino acid sequence at positions 19 to 410 in SEQ ID NO:2;
(c) amino acid residues n to 410 of SEQ ID NO:2, where n is an integer in the range of 2 to 49;
(d) amino acid residues 1 to m of SEQ ID NO:2, where m is an integer in the range of 381 to 410;
(e) amino acid residues n to m of SEQ ID NO:2, where n is an integer in the range of 2 to 49 and m is an integer in the range of 381 to 410;
(f) a polypeptide comprising amino acids 342–378 of SEQ ID NO:2;
(g) the amino acid sequence of the BAIT polypeptide having the complete amino acid sequence encoded by the cDNA clone contained in ATCC Deposit No. 97722;
(h) the amino acid sequence of the complete polypeptide, excluding the N-terminal methionine residue, which amino acid sequence is encoded by the cDNA clone contained in ATCC Deposit No. 97722;
(i) the amino acid sequence of the mature BAIT polypeptide having the amino acid sequence encoded by the cDNA clone contained in ATCC Deposit No. 97722;
(j) a portion of the complete amino acid sequence encoded by the cDNA clone contained in ATCC Deposit 97722 wherein said portion excludes up to 48 amino acid residues from the amino terminus of said complete amino acid sequence;
(k) a portion of the complete amino acid sequence encoded by the cDNA clone contained in ATCC Deposit 97722 wherein said portion excludes up to 30 amino acid residues from the C-terminus of said complete amino acid sequence; and
(l) a portion of the complete amino acid sequence encoded by the cDNA clone contained in ATCC Deposit 97722 wherein said portion excludes up to 48 amino acid residues from the amino terminus and up to 30 amino acids from the C-terminus of said complete amino acid sequence.
2. The method of claim 1 , wherein the method further comprises coadministration of acetylsalicylic acid.